Characteristics and Outcome of Patients Hospitalised for Lower Extremity Peripheral Artery Disease in France: The COPART Registry

European Journal of Vascular and Endovascular Surgery

Volumn 39, Issue 5, 2010, Pages 577-585

  Cambou, J P ^a   Aboyans, V ^b,c   Constans, J ^d   Lacroix, P ^b,c   Dentans, C ^e   Bura, A ^a,e  

^a CHU RANGUEIL   (France)

^b Dupuytren University Hospital   (France)

^c UNIVERSITY OF LIMOGES   (France)

^d HÔPITAL SAINT ANDRÉ   (France)

^e INSERM   (France)

Author keywords

Outcomes; Peripheral artery disease; Registry; Study design

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGE; AGED; AMPUTATION; ANKLE BRACHIAL INDEX; ARTICLE; BYPASS SURGERY; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG THERAPY; EVIDENCE BASED MEDICINE; FEMALE; FRANCE; GANGRENE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HOSPITAL PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTERMITTENT CLAUDICATION; LEG REVASCULARIZATION; LEG ULCER; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT COMPLIANCE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER; REST; SMOKING;

AGED; AGED, 80 AND OVER; AMPUTATION; ANGIOPLASTY, BALLOON; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; EVIDENCE-BASED MEDICINE; FEMALE; FRANCE; GANGRENE; GUIDELINE ADHERENCE; HOSPITAL MORTALITY; HOSPITALIZATION; HOSPITALS, UNIVERSITY; HUMANS; INTERMITTENT CLAUDICATION; ISCHEMIA; KAPLAN-MEIERS ESTIMATE; LEG ULCER; LENGTH OF STAY; LOWER EXTREMITY; MALE; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PERIPHERAL VASCULAR DISEASES; PRACTICE GUIDELINES AS TOPIC; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES;

EID: 77951662317     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2010.02.009     Document Type: Article

References (22)

1. Libby P. Changing concepts of atherogenesis. J Intern Med 247 3 (2000 Mar) 349-358
2. Bertelé V., Roncagnioni M.C., Pangrazzi J., Terzian E., and Tognoni G. Clinical outcomes and its predictors in 1560 patients with critical leg ischemia. Eur J Vasc Endovasc Surg 18 5 (1999 Nov) 401-410
3. Cimminiello C. PAD epidemiology and pathophysiology. Thromb Res 106 6 (2002 jun 1) 295-301
4. Norgren L., Hiatt W.R., Dormandy J.A., Nehler M.R., Harris F.A., Fowkes F.G.R., and on behalf of the TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg 33 Suppl. 1 (2007) S1-S75
5. Diehm C., Lange S., Darius H., Pittrow D., von Stritzky B., Tepohl G., et al. Association of low ankle brachial index with high mortality in primary care. Eur Heart J 27 14 (2006 Jul) 1743-1749
6. Cacoub P.P., Abola M.T., Baumgartner I., Bhatt D.L., Creager M.A., Liau C.S., et al., REACH Registry Investigators. Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Atherosclerosis 204 2 (2009 Jun) 86-92
7. Feringa H.H., Karagiannis S.E., van Waning V.H., Boersma E., Schouten O., Bax J.J., et al. The effect of intensified lipid-lowering therapy on long-term prognosis in patients with peripheral arterial disease. J Vasc Surg 45 5 (2007 May) 936-943
8. Blacher J., Cacoub P., Luizy F., Mourad J.J., Levesque H., Benelbaz J., et al. Peripheral arterial disease versus other localizations of vascular disease: the ATTEST study. J Vasc Surg 44 2 (2006 Aug) 314-318
9. Cacoub P., Cambou J.P., Kownator S., Belliard J.P., Beregi J.P., Branchereau A., et al. Prevalence of peripheral arterial disease in high-risk patients using ankle-brachial index in general practice: a cross-sectional study. Int J Clin Pract 63 1 (2009 Jan) 2-3
10. Sabouret P., Cacoub P., Dallongeville J., Krempf M., Mas J.L., Pinel J.F., et al., REACH Registry investigators. REACH: international prospective observational registry in patients at risk of atherothrombotic events. Results for the French arm at baseline and one year. Arch Cardiovasc Dis 101 2 (2008 Feb) 81-88
11. Tartière J.M., Kesri-Tartière L., Rusinaru D., Lévy F., and Tribouilloy C. Vascular disease as a predictor of long-term mortality in patients hospitalized for new-onset heart failure. Arch Cardiovasc Dis 102 1 (2009 Jan) 11-18
12. Vaysse N., Cambou J.P., Labro S., Guilhem J.M., Severac D., Boccalon H., et al. Characteristics and one-year follow-up of patients with peripheral arterial disease. Initial results of the COPART I registry (Caracteristiques et devenir à un an des patients artériopathes hospitalises du registre COPART-Fr). Ann Cardiol Angeiol 56 2 (2007 Apr) 74-81
13. Rutherford R.B., Baker J.D., Ernst C., Johnson K.W., Porter J.M., Ahn S., et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 26 (1997 Sep) 517-538
14. Bhatt D.L., Steg P.G., Ohman E.M., Hirsch A.T., Ikeda Y., Mas J.L., et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 295 2 (2006 Jan 11) 180-189
15. Cacoub P.P., Bhatt D.L., Steg P.G., Topol E.J., Creager M.A., and CHARISMA Investigators. Patients with peripheral arterial disease in the CHARISMA trial. Eur Heart J 30 2 (2009 Jan) 192-201
16. Ostergren J., Sleight P., Dagenais G., Danisa K., Bosch J., Qilong Y., et al., HOPE study investigators. Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease. Eur Heart J 25 1 (2004 Jan) 17-24
17. Cacoub P.P., Abola M.T., Baumgartner I., Bhatt D.L., Creager M.A., Liau C.S., et al., on behalf of the REACH Registry Investigators. (REACH) Registry. Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the REACH registry. Atherosclerosis 204 2 (2009 Jan) 86-92
18. Henke P.K., Blackburn S., Proctor M.C., Stevens J., Mukherjee D., Rajagopalin S., et al. Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality. J Vasc Surg 39 2 (2004 Feb) 357-365
19. Hirsch A.T., and Gotto Jr. A.M. Undertreatment of dyslipidemia in peripheral arterial disease and other high-risk populations: an opportunity for cardiovascular disease reduction. Vasc Med 7 4 (2002) 323-331
20. Bismuth J., Klitfod L., and Sillesen H. The lack of cardiovascular risk factor management in patients with critical limb ischaemia. Eur J Vasc Endovasc Surg 21 2 (2001 Feb) 143-146
21. Fellström B.C., Jardine A.G., Schmieder R.E., Holdaas H., Bannister K., Beutler J., et al., AURORA Study Group. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 360 14 (2009 Apr 2) 1395-1407
22. Kjekshus J., Apetrei E., Barrios V., Böhm M., Cleland J.G., Cornel J.H., et al., CORONA Group. Rosuvastatin in older patients with systolic heart failure. N Engl J Med 357 22 (2007 Nov 29) 248-261